Literature DB >> 17217125

Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis.

O Oxlade1, K Schwartzman, D Menzies.   

Abstract

OBJECTIVE: Interferon-gamma release assays (IGRA) are now available alternatives to tuberculin skin testing (TST) for detection of latent tuberculosis infection (LTBI). We compared the cost-effectiveness of TST and IGRA in different populations and clinical situations, and with variation of a number of parameters.
METHODS: Markov modelling was used to compare expected TB cases and costs over 20 years following screening for TB with different strategies among hypothetical cohorts of foreign-born entrants to Canada, or contacts of TB cases. The less expensive commercial IGRA, Quanti-FERON-TB Gold (QFT), was examined. Model inputs were derived from published literature.
RESULTS: For entering immigrants, screening with chest radiograph (CXR) would be the most and QFT the least cost-effective. Sequential screening with TST then QFT was more cost-effective than QFT alone in all scenarios, and more cost-effective than TST alone in selected subgroups. Among close and casual contacts, screening with TST or QFT would be cost saving; savings with TST would be greater than with QFT, except in contacts who were bacille Calmette-Guérin (BCG) vaccinated after infancy.
CONCLUSIONS: Screening for LTBI, with TST or QFT, is cost-effective only if the risk of disease is high. The most cost-effective use of QFT is to test TST-positive persons.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17217125

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  53 in total

1.  Cost effectiveness of interferon-gamma release assay for tuberculosis screening of rheumatoid arthritis patients prior to initiation of tumor necrosis factor-α antagonist therapy.

Authors:  Akiko Kowada
Journal:  Mol Diagn Ther       Date:  2010-12-01       Impact factor: 4.074

2.  Evidence-based clinical guidelines for immigrants and refugees.

Authors:  Kevin Pottie; Christina Greenaway; John Feightner; Vivian Welch; Helena Swinkels; Meb Rashid; Lavanya Narasiah; Laurence J Kirmayer; Erin Ueffing; Noni E MacDonald; Ghayda Hassan; Mary McNally; Kamran Khan; Ralf Buhrmann; Sheila Dunn; Arunmozhi Dominic; Anne E McCarthy; Anita J Gagnon; Cécile Rousseau; Peter Tugwell
Journal:  CMAJ       Date:  2010-06-07       Impact factor: 8.262

Review 3.  Recent advances in testing for latent TB.

Authors:  Neil W Schluger; Joseph Burzynski
Journal:  Chest       Date:  2010-12       Impact factor: 9.410

4.  The QuantiFERON-TB-GOLD assay for tuberculosis screening in healthcare workers: a cost-comparison analysis.

Authors:  Benjamin D Fox; Mordechai R Kramer; Zohar Mor; Rachel Preiss; Victoria Rusanov; Leonardo Fuks; Nir Peled; Ilanit Haim; Meir Raz; David Shitrit
Journal:  Lung       Date:  2009-10-15       Impact factor: 2.584

5.  Priorities for screening and treatment of latent tuberculosis infection in the United States.

Authors:  Benjamin P Linas; Angela Y Wong; Kenneth A Freedberg; C Robert Horsburgh
Journal:  Am J Respir Crit Care Med       Date:  2011-09-01       Impact factor: 21.405

6.  Reducing the risk of infection in a 74-year-old man who is to receive prednisone.

Authors:  Daniel M Shafran; Paul E Bunce; Wayne L Gold
Journal:  CMAJ       Date:  2014-07-14       Impact factor: 8.262

7.  Screening immigrants for latent tuberculosis: do we have the resources?

Authors:  Jonathon Campbell; Fawziah Marra; Victoria Cook; James Johnston
Journal:  CMAJ       Date:  2014-01-27       Impact factor: 8.262

Review 8.  [Mantoux versus immunoferon-gamma test for diagnosis of latent tuberculosis infection in TB patient contacts].

Authors:  Antonio Fernández Arias
Journal:  Aten Primaria       Date:  2010-04-08       Impact factor: 1.137

9.  Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis.

Authors:  Anil Pooran; Helen Booth; Robert F Miller; Geoff Scott; Motasim Badri; Jim F Huggett; Graham Rook; Alimuddin Zumla; Keertan Dheda
Journal:  BMC Pulm Med       Date:  2010-02-22       Impact factor: 3.317

10.  Evaluation of the tuberculin skin test and the interferon-gamma release assay for TB screening in French healthcare workers.

Authors:  Dominique Tripodi; Benedicte Brunet-Courtois; Virginie Nael; Marie Audrain; Edmond Chailleux; Patrick Germaud; Frederique Naudin; Jean-Yves Muller; Martine Bourrut-Lacouture; Marie-Henriette Durand-Perdriel; Claire Gordeeff; Guyonne Guillaumin; Marietherese Houdebine; Francois Raffi; David Boutoille; Charlotte Biron; Gilles Potel; Claude Roedlich; Christian Geraut; Anja Schablon; Albert Nienhaus
Journal:  J Occup Med Toxicol       Date:  2009-11-30       Impact factor: 2.646

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.